Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Predictors of insulin resistance among Hispanic adults infected with or at risk of infection with the human immunodeficiency virus and hepatitis C virus.

Castaneda-Sceppa C, Bermudez OI, Wanke C, Forrester JE.

J Viral Hepat. 2008 Dec;15(12):878-87. doi: 10.1111/j.1365-2893.2008.01021.x.

2.

Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease.

Guaraldi G, Lonardo A, Ballestri S, Zona S, Stentarelli C, Orlando G, Carli F, Carulli L, Roverato A, Loria P.

Arch Med Res. 2011 Nov;42(8):690-7. doi: 10.1016/j.arcmed.2011.12.009. Epub 2012 Jan 4.

PMID:
22227046
3.

Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.

Halfon P, Pénaranda G, Carrat F, Bedossa P, Bourlière M, Ouzan D, Renou C, Tran A, Rosenthal E, Wartelle C, Delasalle P, Cacoub P.

Aliment Pharmacol Ther. 2009 Jul;30(1):61-70. doi: 10.1111/j.1365-2036.2009.03995.x. Epub 2009 Mar 9.

4.

The individual and combined influence of HIV and hepatitis C virus on dyslipidaemia in a high-risk Hispanic population.

Forrester JE, McGovern BH, Rhee MS, Sterling RK.

HIV Med. 2009 Oct;10(9):555-63. doi: 10.1111/j.1468-1293.2009.00722.x. Epub 2009 Jun 1.

5.

Associations between lipodystrophy or antiretroviral medications and cirrhosis in patients with HIV infection or HIV/HCV coinfection.

Ioannou GN, Bryson CL, Weiss NS, Boyko EJ.

Eur J Gastroenterol Hepatol. 2015 May;27(5):577-84. doi: 10.1097/MEG.0000000000000290.

PMID:
25769096
6.

Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy.

Duong M, Petit JM, Piroth L, Grappin M, Buisson M, Chavanet P, Hillon P, Portier H.

J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):245-50.

PMID:
11464143
7.

IL28B polymorphism, pretreatment CXCL10, and HCV RNA levels predict treatment response in racially diverse HIV/HCV coinfected and HCV monoinfected patients.

Zeremski M, Dimova RB, Makeyeva J, Sipley JD, Jacobson IM, Rennert H, Talal AH.

J Acquir Immune Defic Syndr. 2013 May 1;63(1):9-16. doi: 10.1097/QAI.0b013e31828323c1.

PMID:
23274935
8.

Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.

Loko MA, Bani-Sadr F, Winnock M, Lacombe K, Carrieri P, Neau D, Morlat P, Serfaty L, Dabis F, Salmon D; ANRS CO 13 HEPAVIH Study Group.

J Viral Hepat. 2011 Jul;18(7):e307-14. doi: 10.1111/j.1365-2893.2010.01417.x. Epub 2011 Jan 11.

PMID:
21692942
9.

Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.

Avihingsanon A, Jitmitraparp S, Tangkijvanich P, Ramautarsing RA, Apornpong T, Jirajariyavej S, Putcharoen O, Treeprasertsuk S, Akkarathamrongsin S, Poovorawan Y, Matthews GV, Lange JM, Ruxrungtham K; HIV-NAT125 study team.

J Gastroenterol Hepatol. 2014 Sep;29(9):1706-14. doi: 10.1111/jgh.12613.

PMID:
24730732
10.

Hepatitis C in Children Co-infected With Human Immunodeficiency Virus.

Indolfi G, Bartolini E, Serranti D, Azzari C, Resti M.

J Pediatr Gastroenterol Nutr. 2015 Oct;61(4):393-9. doi: 10.1097/MPG.0000000000000895. Review.

PMID:
26147631
11.

Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients.

Merchante N, Macías J, Ramayo E, Vergara S, García-García JA, Mira JA, Corzo JE, Gómez-Mateos JM, Lozano F, Pineda JA.

J Viral Hepat. 2006 Jul;13(7):449-56.

PMID:
16792538
12.

High prevalence of GB virus C/hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: evidence for sexual transmission.

Nerurkar VR, Chua PK, Hoffmann PR, Dashwood WM, Shikuma CM, Yanagihara R.

J Med Virol. 1998 Oct;56(2):123-7.

PMID:
9746067
13.

Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.

Lo Re V 3rd, Volk J, Newcomb CW, Yang YX, Freeman CP, Hennessy S, Kostman JR, Tebas P, Leonard MB, Localio AR.

Hepatology. 2012 Nov;56(5):1688-98. doi: 10.1002/hep.25866. Epub 2012 Oct 14.

14.

Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999-2007.

Vellozzi C, Buchacz K, Baker R, Spradling PR, Richardson J, Moorman A, Tedaldi E, Durham M, Ward J, Brooks JT; HOPS Investigators.

J Viral Hepat. 2011 May;18(5):316-24. doi: 10.1111/j.1365-2893.2010.01299.x.

PMID:
20367803
16.

Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients: the HEPADOSE study.

Dominguez S, Ghosn J, Peytavin G, Guiguet M, Tubiana R, Valantin MA, Murphy R, Bricaire F, Benhamou Y, Katlama C.

J Antimicrob Chemother. 2010 Nov;65(11):2445-9. doi: 10.1093/jac/dkq320. Epub 2010 Sep 2.

PMID:
20813809
17.

Effects of hepatitis C virus infection on the pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected patients.

Di Biagio A, Rosso R, Loregian A, Pagni S, Sormani MP, Cenderello G, Palù G, Viscoli C.

J Infect Chemother. 2012 Aug;18(4):587-90. doi: 10.1007/s10156-012-0402-y. Epub 2012 Mar 16.

PMID:
22422300
18.

The association of HIV viral load with indirect markers of liver injury.

Forrester JE, Rhee MS, McGovern BH, Sterling RK, Knox TA, Terrin N.

J Viral Hepat. 2012 Feb;19(2):e202-11. doi: 10.1111/j.1365-2893.2011.01529.x. Epub 2011 Dec 2.

19.

Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.

Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P.

Ann Hepatol. 2008 Apr-Jun;7(2):152-6.

PMID:
18626434
20.

Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.

Mendeni M, Focà E, Gotti D, Ladisa N, Angarano G, Albini L, Castelnuovo F, Carosi G, Quiros-Roldan E, Torti C.

Clin Infect Dis. 2011 May;52(9):1164-73. doi: 10.1093/cid/cir071.

PMID:
21467023

Supplemental Content

Support Center